INTERNATIONAL PATENT: ABBVIE INC., ABBVIE DEUTSCHLAND GMBH & CO. KG FILES APPLICATION FOR "LUTIKIZUMAB FOR USE IN A TREATMENT OF HIDRADENITIS SUPPURATIVA"

GENEVA, July 14 -- ABBVIE INC. (1 North Waukegan RoadNorth Chicago, IL 60064), ABBVIE DEUTSCHLAND GMBH & CO. KG (Mainzer Str. 8165189 Wiesbaden) filed a patent application (PCT/US2025/010066) for "LUTIKIZUMAB FOR USE IN A TREATMENT OF HIDRADENITIS SUPPURATIVA" on Jan 02, 2025. With publication no. WO/2025/147499, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AKBARI, Mona (C/o Abbvie, Inc.1 North Waukegan RoadNorth Chicago, IL 60064), WILLIAMS, David, A. (C/o Abbvie, Inc.1 North Waukegan RoadNorth Chicago, IL 60064), PAN...